TUMOR NECROSIS FACTOR-α INHIBITS ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN DORSAL ROOT GANGLION NEURONS VIA β-CATENIN SIGNALING

被引:8
作者
Yang, Y. [1 ]
Wu, H. [2 ]
Yan, J. -Q. [1 ]
Song, Z. -B. [1 ]
Guo, Q. -L. [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Sch Med, Dept Med Oncol, Hunan Prov Tumor Hosp,Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China
关键词
tumor necrosis factor-alpha; angiotensin II receptor type 1; dorsal root ganglion neuron; beta-catenin; p38 mitogen-activated protein kinase; glycogen synthase kinase-3 beta; NEUROPATHIC PAIN; SPINAL-CORD; TNF-ALPHA; ETANERCEPT; PATHWAY; SYSTEM; NERVE; MODULATION; ACTIVATION; LACKING;
D O I
10.1016/j.neuroscience.2013.06.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Both tumor necrosis factor (TNF)-alpha and the angiotensin (Ang) II/angiotensin II receptor type 1 (AT1) axis play important roles in neuropathic pain and nociception. In the present study, we explored the interaction between the two systems by examining the mutual effects between TNF-alpha and the Ang II/AT1 receptor axis in dorsal root ganglion (DRG) neurons. Rat DRG neurons were treated with TNF-alpha in different concentrations for different lengths of time in the presence or absence of transcription inhibitor actinomycin D, TNF receptor 1 (TNFR1) inhibitor SPD304, p-catenin signaling inhibitor CCT031374, or different kinase inhibitors. TNF-alpha decreased the AT1 receptor mRNA level as well as the AT1a receptor promoter activity in a dose-dependent manner within 30 h, which led to dose-dependent inhibition of Ang II-binding AT1 receptor level on the cell membrane. Actinomycin D (1 mg/ml), SPD304 (50 mu M), p38 mitogen-activated protein kinase (MAPK) inhibitor PD169316 (25 mu M), and CCT031374 (50 mu M) completely abolished the inhibitory effect of TNF-alpha on AT1 receptor expression. TNF-alpha dose-dependently increased soluble beta-catenin and phosphorylated GSK-3 beta levels, which was blocked by SPD304 and PD169316. In DRG neurons treated with AT2 receptor agonist CGP421140, or Ang II with or without AT1 receptor antagonist losartan or AT2 receptor antagonist PD123319 for 30 h, we found that Ang II and Ang II + PD123319 significantly decreased TNF-alpha expression, whereas CPG421140 and Ang II + losartan increased TNF-alpha expression. In conclusion, we demonstrate that TNF-alpha inhibits AT1 receptor expression at the transcription level via TNFR1 in rat DRG neurons by increasing the soluble beta-catenin level through the p38 MAPK/GSK-3 beta pathway. In addition, Ang II appears to inhibit and induce TNF-alpha expression via the AT1 receptor and the AT2 receptor in DRG neurons, respectively. This is the first evidence of crosstalk
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [1] Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons
    Tan, Rong
    Cao, Lijun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (02) : 919 - 925
  • [2] Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes
    Rosa, Arianna Carolina
    Rattazzi, Lorenza
    Miglio, Gianluca
    Collino, Massimo
    Fantozzi, Roberto
    INFLAMMATION RESEARCH, 2012, 61 (04) : 311 - 317
  • [3] Tumor necrosis factor-α potentiates the effects of angiotensin II on subfornical organ neurons
    Simpson, Nick J.
    Ferguson, Alastair, V
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 315 (03) : R425 - R433
  • [4] Tumor necrosis factor-α upregulates angiotensin II type 1 receptors on cardiac fibroblasts
    Gurantz, D
    Cowling, RT
    Villarreal, FJ
    Greenberg, BH
    CIRCULATION RESEARCH, 1999, 85 (03) : 272 - 279
  • [5] Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells
    Takao, Toshihiro
    Horino, Taro
    Matsumoto, Reiko
    Shimamura, Yoshiko
    Ogata, Koji
    Inoue, Kousuke
    Taniguchi, Yoshinori
    Taguchi, Takafumi
    Terada, Yoshio
    RENAL FAILURE, 2015, 37 (01) : 160 - 164
  • [6] Direct Application of the Tumor Necrosis Factor-α Inhibitor, Etanercept, Into a Punctured Intervertebral Disc Decreases Calcitonin Gene-Related Peptide Expression in Rat Dorsal Root Ganglion Neurons
    Horii, Manato
    Orita, Sumihisa
    Nagata, Maiko
    Takaso, Masashi
    Yamauchi, Kazuyo
    Yamashita, Masaomi
    Inoue, Gen
    Eguchi, Yawara
    Ochiai, Nobuyasu
    Kishida, Shunji
    Aoki, Yasuchika
    Ishikawa, Tetsuhiro
    Arai, Gen
    Miyagi, Masayuki
    Kamoda, Hiroto
    Kuniyoshi, Kazuki
    Suzuk, Miyako
    Nakamura, Junichi
    Toyone, Tomoaki
    Takahashi, Kazuhisa
    Ohtori, Seiji
    SPINE, 2011, 36 (02) : E80 - E85
  • [7] Angiotensin II Receptor Blocker Improves Tumor Necrosis Factor-α-Induced Cytotoxicity via Antioxidative Effect in Human Glomerular Endothelial Cells
    Izawa-Ishizawa, Yuki
    Ishizawa, Keisuke
    Sakurada, Takumi
    Imanishi, Masaki
    Miyamoto, Licht
    Fujii, Shoko
    Taira, Hironori
    Kihira, Yoshitaka
    Ikeda, Yasumasa
    Hamano, Shuichi
    Tomita, Shuhei
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    PHARMACOLOGY, 2012, 90 (5-6) : 324 - 331
  • [8] TUMOR NECROSIS FACTOR-α INCREASES BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN TRIGEMINAL GANGLION NEURONS IN AN ACTIVITY-DEPENDENT MANNER
    Balkowiec-Iskra, E.
    Vermehren-Schmaedick, A.
    Balkowiec, A.
    NEUROSCIENCE, 2011, 180 : 322 - 333
  • [9] Nociceptor-like rat dorsal root ganglion neurons express the angiotensin-II AT2 receptor throughout development
    Benitez, Sergio
    Seltzer, Alicia
    Acosta, Cristian
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2017, 56 : 10 - 17
  • [10] Intrathecal Ultra-Low Dose Naloxone Enhances the Antihyperalgesic Effects of Morphine and Attenuates Tumor Necrosis Factor-α and Tumor Necrosis Factor-α Receptor 1 Expression in the Dorsal Horn of Rats with Partial Sciatic Nerve Transection
    Yang, Chih-Ping
    Cherng, Chen-Hwan
    Wu, Ching-Tang
    Huang, Hui-Yi
    Tao, Pao-Luh
    Lee, Sing-Ong
    Wong, Chih-Shung
    ANESTHESIA AND ANALGESIA, 2013, 117 (06) : 1493 - 1502